These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4276573)

  • 21. Studies on the interaction of reserpine, d-amphetamine, apomorphine and 5-hydroxytryptophan.
    Goetz C; Klawans HL
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):119-30. PubMed ID: 4547506
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
    Mandel RJ
    Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Drug-induced stereotyped behavior: similarities and differences.
    Wallach MB
    Psychopharmacol Bull; 1974 Jul; 10(3):12-3. PubMed ID: 4153704
    [No Abstract]   [Full Text] [Related]  

  • 24. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
    Leahy JP; Stern WC; Resnick O; Morgane PJ
    Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
    Costall B; Naylor RJ; Pycock C
    J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 29. GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
    Stevens J; Wilson K; Foote W
    Psychopharmacologia; 1974; 39(2):105-19. PubMed ID: 4155802
    [No Abstract]   [Full Text] [Related]  

  • 30. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and antireserpine activity of peptides of L-dopa.
    Felix AM; Winter DP; Wang SS; Kulesha ID; Pool WR; Hane DL; Sheppard H
    J Med Chem; 1974 Apr; 17(4):422-6. PubMed ID: 4857423
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1974 Mar; 13(3):189-97. PubMed ID: 4858216
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of somatostatin and its fragments on turning behaviour induced by unilateral substantia nigra lesion in the rat.
    Vécsei L; Bollók I; Varga J; Penke B; Telegdy G
    Acta Physiol Hung; 1984; 64(2):157-62. PubMed ID: 6149666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A potential anti-parkinson drug, N-n-propyl-N-n-butyl-beta-(3,4-dihydroxyphenyl)ethylamine hydrochloride, and its effects in intact and nigra-lesioned rats.
    Ginos JZ; Brown FC
    J Med Chem; 1978 Feb; 21(2):155-60. PubMed ID: 563918
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory effects of amphetamine, L-DOPA and apomorphine on morphine-induced behavioural excitation of rats.
    Ayhan IH; Randrup A
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):283-92. PubMed ID: 4748782
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological basis for N-n-propylnorapomorphine induced stereotypic cage climbing and behavioral arousal in mice.
    Wilcox RE; Riffee WH; Smith RV
    Pharmacol Biochem Behav; 1979 Dec; 11(6):653-9. PubMed ID: 43980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.